Name:  ___                  Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: SURGERY
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Morbid obesity
 
Major Surgical or Invasive Procedure:
___: laparoscopic sleeve gastrectomy

 
History of Present Illness:
Per Dr. ___: She has made multiple attempts at weight loss 
using diet and exercise with no long lasting successful weight 
loss.  She is interested in weight loss surgery for help in this 
endeavor.  

She has a weight of 286.3 pounds as of ___ with her initial 
screen weight of 289.4 pounds on ___, height of 66.25 inches 
and BMI of 45.9.  

 
Past Medical History:
Her medical history is noted for:
1)  hyperlipidemia with elevated triglycerides
2)  vitamin D deficiency
3)  hepatic steatosis by ultrasound study
4)  pre-diabetes with hemoglobin A1c of 6.4%

Her surgical history includes:
1)  placement of metal plate in her left forearm in ___ s/p MVA
2)  breast reduction in ___

 
Social History:
___
Family History:
Her family history is noted for both parents living father with 
hyperlipidemia, diabetes, cancer, obesity; mother living with 
hyperlipidemia; maternal grandmother with coronary artery 
disease/peripheral vascular disease; paternal grandfather 
deceased of MI with history of diabetes.  She is single with no
children.

 
Physical Exam:
VS: 98.4   70   134/83   20   96RA

Constitutional: NAD
Neuro: alert and oriented x 3
Cardiac: regular rate and rhythm, no murmurs appreciated
Resp: clear to auscultation, bilaterally
Abd: abdomen soft, non-tender, non-distended, no rebound 
tenderness or guarding
Wounds: abdominal incisions with steri-strips, CDI
Ext: no edema
 
Pertinent Results:
___ 06:04AM BLOOD Hct-35.8
___ 12:29PM BLOOD Hct-36.7

UGI SGL W/O KUB:
IMPRESSION:  
No evidence of leak or obstruction. 

 
Brief Hospital Course:
The patient presented to pre-op on ___. Pt was 
evaluated by anaesthesia and taken to the operating room for 
laparoscopic sleeve gastrectomy. There were no adverse events in 
the operating room; please see the operative note for details. 
Pt was extubated, taken to the PACU until stable, then 
transferred to the ward for observation. 

Neuro: The patient was alert and oriented throughout 
hospitalization; pain was initially managed with a PCA and then 
transitioned to oral Roxicet once tolerating a stage 2 diet. 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulmonary: The patient remained stable from a pulmonary 
standpoint; vital signs were routinely monitored. Good pulmonary 
toilet, early ambulation and incentive spirometry were 
encouraged throughout hospitalization. 
GI/GU/FEN: The patient was initially kept NPO.  A methylene blue 
dye test (POD0) and  an upper GI study (POD1) were both negative 
for a leak, therefore, the diet was advanced sequentially to a 
Bariatric Stage 3 diet, which was well tolerated. Patient's 
intake and output were closely monitored.  
ID: The patient's fever curves were closely watched for signs of 
infection, of which there were none.
HEME: The patient's blood counts were closely watched for signs 
of bleeding, of which there were none.
Prophylaxis: The patient received subcutaneous heparin and ___ 
dyne boots were used during this stay and was encouraged to get 
up and ambulate as early as possible.

At the time of discharge, the patient was doing well, afebrile 
with stable vital signs.  The patient was tolerating a stage 3 
diet, ambulating, voiding without assistance, and pain was well 
controlled.  The patient received discharge teaching and 
follow-up instructions with understanding verbalized and 
agreement with the discharge plan.

 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. dextroamphetamine-amphetamine 10 mg oral BID 
2. BuPROPion 75 mg PO BID 
3. Multivitamins 1 TAB PO DAILY 

 
Discharge Medications:
1. BuPROPion 75 mg PO BID 
2. Docusate Sodium (Liquid) 100 mg PO BID:PRN constipation 
RX *docusate sodium [Diocto] 50 mg/5 mL 10 mL by mouth twice a 
day Refills:*0
3. OxycoDONE Liquid 5 mg PO Q4H:PRN pain 
RX *oxycodone 5 mg/5 mL 5 mL by mouth every four (4) hours 
Refills:*0
4. Ranitidine (Liquid) 150 mg PO BID 
RX *ranitidine HCl 15 mg/mL 10 mL by mouth twice a day 
Refills:*0
5. Multivitamins 1 TAB PO DAILY 
6. dextroamphetamine-amphetamine 10 mg ORAL BID 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Morbid obesity
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Discharge Instructions: Please call your surgeon or return to 
the emergency department if you develop a fever greater than 
101.5, chest pain, shortness of breath, severe abdominal pain, 
pain unrelieved by your pain medication, severe nausea or 
vomiting, severe abdominal bloating, inability to eat or drink, 
foul smelling or colorful drainage from your incisions, redness 
or swelling around your incisions, or any other symptoms which 
are concerning to you.

Diet: Stay on Stage III diet until your follow up appointment. 
Do not self advance diet, do not drink out of a straw or chew 
gum.

Medication Instructions:
Resume your home medications, CRUSH ALL PILLS.
You will be starting some new medications:
1.  You are being discharged on medications to treat the pain 
from your operation. These medications will make you drowsy and 
impair your ability to drive a motor vehicle or operate 
machinery safely. You MUST refrain from such activities while 
taking these medications.
2. You should begin taking a chewable complete multivitamin with 
minerals. No gummy vitamins.
3. You will be taking Zantac liquid ___ mg twice daily for one 
month. This medicine prevents gastric reflux.
4. You should take a stool softener, Colace, twice daily for 
constipation as needed, or until you resume a normal bowel 
pattern.
5. You must not use NSAIDS (non-steroidal anti-inflammatory 
drugs) Examples are Ibuprofen, Motrin, Aleve, Nuprin and 
Naproxen. These agents will cause bleeding and ulcers in your 
digestive system.

Activity:
No heavy lifting of items ___ pounds for 6 weeks. You may 
resume moderate exercise at your discretion, no abdominal 
exercises.

Wound Care:
You may shower, no tub baths or swimming. 
If there is clear drainage from your incisions, cover with 
clean, dry gauze. 
Your steri-strips will fall off on their own. Please remove any 
remaining strips ___ days after surgery.
Please call the doctor if you have increased pain, swelling, 
redness, or drainage from the incision sites. 

 
Followup Instructions:
___